Trading Window Closure Announced by Sandu Pharmaceuticals Ltd for Q Ended 31st March 2026

Sandu Pharmaceuticals Ltd has announced the closure of the trading window for the quarter ended 31st March 2026. The closure is in accordance with the 'Code of Conduct for Prevention of Insider Trading' of the company, SEBI (Prohibition of Insider Trading) Regulations, 2015, and a clarification given by BSE. The trading window will remain closed from Wednesday, 01 April 2026 till 48 hours after the declaration of the financial results of the company for the quarter and year ended 31st March 2026. This restriction applies to Directors, KMPs, Promoters, and Promoters Group, Designated Persons, and their immediate relatives covered under the Code. The date of the Board Meeting for consideration of the Audited Financial Results of the Company for the Quarter and Year ended 31 March 2026 will be intimated in due course.